Screen-detected breast cancers have an improved 5-year recurrence free interval compared to interval and non-screened breast cancers: a population-based study

被引：0
|
作者：
de Munck, L. [1 ]
Eijkelboom, A. [1 ]
Otten, H. [2 ]
Broeders, M. [3 ]
Siesling, S. [1 ]
机构：
[1] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands
[2] Radboud Univ Nijmegen, Hlth Evidence, Med Ctr, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Hlth Evidence, Med Ctr, Dutch Expert Ctr Screening, Nijmegen, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 175卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
97 (PB-097
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [31] Interval Breast Cancers Are Associated with More Aggressive Pathologic Characteristics Compared to Screen-Detected Cancers: A Nested Case Control Study from a Canadian Breast Screening Program
    Rayson, D.
    Payne, J. I.
    Barnes, P. J.
    MacIntoshi, R. F.
    Foley, T.
    Burns, A. M.
    Younis, T.
    Caines, J. S.
    MODERN PATHOLOGY, 2009, 22 : 63A - 64A
  • [32] Interval Breast Cancers Are Associated with More Aggressive Pathologic Characteristics Compared to Screen-Detected Cancers: A Nested Case Control Study from a Canadian Breast Screening Program
    Rayson, D.
    Payne, J. I.
    Barnes, P. J.
    MacIntosh, R. F.
    Abdolell, M.
    Foley, T.
    Burns, A. M.
    Younis, T.
    Caines, J. S.
    LABORATORY INVESTIGATION, 2009, 89 : 63A - 64A
  • [33] Tumour characteristics of screen-detected and interval cancers in the Flemish Breast Cancer Screening Programme: A mammographic breast density study
    Timmermans, Lore
    De Brabander, Isabel
    Van Damme, Nancy
    Bleyen, Luc
    Martens, Patrick
    Van Herck, Koen
    Thierens, Hubert
    Bacher, Klaus
    Depypere, Herman
    MATURITAS, 2022, 158 : 55 - 60
  • [34] Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers
    de Munck, Linda
    de Bock, Geertruida H.
    Otter, Renee
    Reiding, Dick
    Broeders, Mireille J. M.
    Willemse, Pax H. B.
    Siesling, Sabine
    BRITISH JOURNAL OF CANCER, 2016, 115 (05) : 517 - 524
  • [35] Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers
    Linda de Munck
    Geertruida H de Bock
    Renée Otter
    Dick Reiding
    Mireille JM Broeders
    Pax HB Willemse
    Sabine Siesling
    British Journal of Cancer, 2016, 115 : 517 - 524
  • [36] Digital versus screen-film mammography in population-based breast cancer screening: Performance indicators and tumor characteristics of screen-detected and interval cancers
    De Munck, L.
    De bock, G. H.
    Otter, R.
    Reiding, D.
    Broeders, M. J. M.
    Willemse, P. H. B.
    Siesling, S.
    CANCER RESEARCH, 2016, 76
  • [37] Interval cancers in breast cancer screening: comparison of stage and biological characteristics with screen-detected cancers or incident cancers in the absence of screening
    Caumo, Francesca
    Vecchiato, Francesca
    Strabbioli, Marzia
    Zorzi, Manuel
    Baracco, Susanna
    Ciatto, Stefano
    TUMORI JOURNAL, 2010, 96 (02): : 198 - 201
  • [38] Breast tumor characteristics as predictors of mammographic detection: Comparison of interval- and screen-detected cancers
    Porter, PL
    El-Bastawissi, AY
    Mandelson, MT
    Lin, MG
    Khalid, N
    Watney, EA
    Cousens, L
    White, D
    Taplin, S
    White, E
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (23) : 2020 - 2028
  • [39] Differences between screen-detected and interval breast cancers among BRCA mutation carriers.
    Pilewskie, Melissa Louise
    Zabor, Emily Craig
    Stempel, Michelle
    Petruolo, Oriana
    Mangino, Debra
    Robson, Mark E.
    Jochelson, Maxine S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers
    Gautier Defossez
    Alexandre Quillet
    Pierre Ingrand
    BMC Cancer, 18
12345